Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Timothy Garrington

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Central Nervous System Neoplasms
2
2024
156
0.700
Why?
Rhabdomyosarcoma
1
2019
72
0.570
Why?
Sarcoma, Ewing
3
2025
97
0.560
Why?
MAP Kinase Kinase Kinases
6
2004
73
0.520
Why?
Kidney Neoplasms
4
2025
403
0.490
Why?
Mitogen-Activated Protein Kinases
8
2004
313
0.410
Why?
Hodgkin Disease
2
2016
138
0.390
Why?
Wilms Tumor
2
2025
86
0.350
Why?
Neuroblastoma
3
2017
160
0.330
Why?
Mitogen-Activated Protein Kinase Kinases
4
2004
134
0.310
Why?
Neoplasms
6
2025
2673
0.310
Why?
Beckwith-Wiedemann Syndrome
1
2008
6
0.300
Why?
Adrenal Gland Neoplasms
2
2014
89
0.300
Why?
Fluorodeoxyglucose F18
1
2009
135
0.300
Why?
Neoplasms, Multiple Primary
1
2008
57
0.290
Why?
Asparaginase
2
1998
30
0.290
Why?
JNK Mitogen-Activated Protein Kinases
5
2004
162
0.280
Why?
Positron-Emission Tomography
1
2009
295
0.280
Why?
MAP Kinase Kinase Kinase 1
3
2005
19
0.280
Why?
Adrenal Cortex Neoplasms
1
2008
63
0.280
Why?
Histiocytosis, Langerhans-Cell
2
2020
37
0.270
Why?
Pancreatitis
2
1998
134
0.260
Why?
Child
24
2025
21989
0.260
Why?
Child, Preschool
18
2025
11105
0.250
Why?
MAP Kinase Kinase Kinase 2
7
2012
12
0.250
Why?
Teratoma
2
2025
114
0.250
Why?
Mast Cells
3
2003
148
0.240
Why?
Nose Neoplasms
1
2025
25
0.230
Why?
Carcinosarcoma
1
2025
21
0.230
Why?
Testicular Neoplasms
2
2017
110
0.230
Why?
Adaptor Proteins, Signal Transducing
4
2003
430
0.230
Why?
Genetic Heterogeneity
1
2025
59
0.230
Why?
Clonal Evolution
1
2025
45
0.230
Why?
Appointments and Schedules
1
2025
89
0.220
Why?
Adolescent
20
2025
21574
0.220
Why?
Paclitaxel
1
2025
230
0.220
Why?
Medical Errors
1
2025
112
0.210
Why?
Fibroblast Growth Factor 2
1
2004
87
0.210
Why?
Catheterization, Central Venous
1
2025
112
0.210
Why?
Biomarkers, Tumor
3
2025
1276
0.200
Why?
Central Nervous System Diseases
1
2024
69
0.200
Why?
Neoplasms, Germ Cell and Embryonal
2
2016
77
0.200
Why?
MAP Kinase Signaling System
3
2008
320
0.200
Why?
Neoplasms, Second Primary
1
2024
118
0.190
Why?
Bone Neoplasms
1
2025
247
0.190
Why?
Parental Leave
1
2022
26
0.190
Why?
Lung Neoplasms
2
2021
2526
0.190
Why?
Single-Cell Analysis
1
2025
313
0.190
Why?
Anemia
1
2023
170
0.190
Why?
Calcium-Calmodulin-Dependent Protein Kinases
2
1999
182
0.180
Why?
Thrombocytopenia
1
2023
200
0.180
Why?
Sarcoma
2
2015
188
0.180
Why?
Pulmonary Blastoma
1
2021
8
0.180
Why?
RNA, Neoplasm
1
2021
82
0.170
Why?
Tomography, X-Ray Computed
2
2021
2697
0.170
Why?
Pituitary Diseases
1
2020
20
0.170
Why?
Circulating Tumor DNA
1
2021
34
0.170
Why?
Stem Cell Factor
1
2000
15
0.170
Why?
Ribonuclease III
1
2021
40
0.170
Why?
Sertoli-Leydig Cell Tumor
1
2020
8
0.170
Why?
Receptors, IgE
1
2000
45
0.170
Why?
Cholestasis
1
2023
235
0.170
Why?
Rhabdomyosarcoma, Embryonal
1
2020
22
0.170
Why?
Fibroblasts
3
2005
996
0.170
Why?
Infant
12
2025
9482
0.170
Why?
DEAD-box RNA Helicases
1
2021
76
0.170
Why?
Pituitary Gland
1
2020
148
0.160
Why?
Lymphohistiocytosis, Hemophagocytic
1
2020
31
0.160
Why?
Humans
39
2025
137782
0.160
Why?
Survival Rate
3
2019
1973
0.150
Why?
Salvage Therapy
2
2025
142
0.150
Why?
Fellowships and Scholarships
1
2022
307
0.150
Why?
Neoplasm Recurrence, Local
1
2025
1080
0.150
Why?
Disease-Free Survival
2
2019
686
0.150
Why?
Proto-Oncogene Proteins B-raf
1
2020
224
0.150
Why?
Polycystic Kidney Diseases
1
2019
76
0.140
Why?
Female
23
2025
73465
0.140
Why?
Male
23
2025
67906
0.140
Why?
Octreotide
1
1998
26
0.140
Why?
Biopsy, Large-Core Needle
1
2017
14
0.140
Why?
Antibodies, Neutralizing
1
2020
286
0.140
Why?
Abdominal Neoplasms
1
2017
39
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2025
1692
0.130
Why?
Cancer Survivors
1
2022
288
0.130
Why?
Cytodiagnosis
1
2017
33
0.130
Why?
Frozen Sections
1
2017
26
0.130
Why?
Seminoma
1
2017
20
0.130
Why?
Interferon-gamma
1
2020
789
0.130
Why?
Quality Improvement
1
2025
1181
0.130
Why?
Cytokines
2
2004
2085
0.130
Why?
Protein Processing, Post-Translational
1
1999
465
0.130
Why?
Tumor Necrosis Factor-alpha
4
2003
1242
0.130
Why?
Enzyme Activation
6
2004
810
0.120
Why?
Retrospective Studies
8
2025
15682
0.120
Why?
Health Planning
1
2015
47
0.120
Why?
Saccharomyces cerevisiae Proteins
1
1999
405
0.120
Why?
Ovarian Neoplasms
1
2020
565
0.110
Why?
Mediastinal Neoplasms
1
2014
45
0.110
Why?
Thoracoscopy
1
2014
56
0.110
Why?
Transcription Factor AP-1
2
2005
92
0.110
Why?
Genetic Predisposition to Disease
2
2021
2427
0.110
Why?
Transition to Adult Care
1
2015
91
0.110
Why?
Arabinonucleosides
1
2013
8
0.110
Why?
Adenine Nucleotides
1
2013
23
0.110
Why?
Xanthogranuloma, Juvenile
1
2013
6
0.110
Why?
Histiocytosis, Sinus
1
2013
8
0.110
Why?
Biopsy
1
2017
1130
0.110
Why?
Disease Management
2
2015
629
0.100
Why?
Carrier Proteins
4
2003
771
0.100
Why?
Ambulatory Care Facilities
1
2015
235
0.100
Why?
Antimetabolites, Antineoplastic
1
2013
94
0.100
Why?
Antibodies, Monoclonal
1
2020
1430
0.100
Why?
Heart Diseases
1
2016
346
0.100
Why?
Hypertrophy, Right Ventricular
1
2012
145
0.090
Why?
Prognosis
5
2025
4039
0.090
Why?
Prevalence
1
2019
2734
0.090
Why?
Diagnostic Imaging
1
2014
332
0.090
Why?
Anesthesia
1
2014
189
0.090
Why?
Gene Expression Regulation
4
2012
2607
0.090
Why?
Receptors, Tumor Necrosis Factor
2
2002
164
0.090
Why?
Signal Transduction
3
2004
5081
0.090
Why?
Program Development
2
2015
368
0.080
Why?
Stem Cells
2
2008
594
0.080
Why?
Ventricular Remodeling
1
2012
268
0.080
Why?
Pediatrics
2
2008
1103
0.080
Why?
Laparoscopy
1
2014
466
0.080
Why?
Subtraction Technique
1
2009
23
0.080
Why?
Primary Health Care
2
2022
1750
0.080
Why?
Young Adult
7
2025
13240
0.080
Why?
Radiopharmaceuticals
1
2009
178
0.070
Why?
Potassium Channels, Voltage-Gated
1
2008
50
0.070
Why?
Myocytes, Cardiac
1
2012
526
0.070
Why?
Adult
7
2025
38023
0.070
Why?
Mutation
4
2025
3959
0.070
Why?
Polymerase Chain Reaction
2
2021
1062
0.070
Why?
Heart Ventricles
1
2012
790
0.070
Why?
Antineoplastic Agents
1
1998
2129
0.070
Why?
Infant, Newborn
4
2023
6084
0.060
Why?
Embryo, Mammalian
2
2005
232
0.060
Why?
Mitogen-Activated Protein Kinase 7
4
2012
20
0.060
Why?
Liver Neoplasms
1
2012
786
0.060
Why?
Leukemia
1
2008
241
0.060
Why?
Risk Assessment
1
2015
3461
0.060
Why?
Near Miss, Healthcare
1
2025
11
0.060
Why?
Hypoxia
1
2012
1112
0.060
Why?
Epidermal Growth Factor
2
2003
177
0.060
Why?
Age Factors
3
2018
3305
0.060
Why?
Cell Line
5
2003
2847
0.060
Why?
Acute Disease
2
1998
1007
0.060
Why?
Education, Medical, Undergraduate
1
2007
188
0.060
Why?
Proto-Oncogene Proteins c-jun
1
2005
55
0.060
Why?
Transcription Factors
2
2021
1719
0.060
Why?
Cord Blood Stem Cell Transplantation
1
2005
99
0.060
Why?
SEER Program
2
2016
227
0.060
Why?
Killer Cells, Natural
1
2008
449
0.060
Why?
Neoplastic Cells, Circulating
1
2025
80
0.060
Why?
MAP Kinase Kinase 4
1
2004
29
0.050
Why?
Phosphorylation
3
2012
1759
0.050
Why?
DNA Copy Number Variations
1
2025
182
0.050
Why?
Antineoplastic Agents, Phytogenic
1
2025
191
0.050
Why?
Genes, jun
1
2003
10
0.050
Why?
Blotting, Western
2
2004
1227
0.050
Why?
Apoptosis
3
2002
2553
0.050
Why?
Myogenic Regulatory Factors
1
2003
57
0.050
Why?
Survival Analysis
2
2018
1325
0.050
Why?
Neoplasm Metastasis
2
2018
658
0.050
Why?
DNA Methylation
1
2008
643
0.050
Why?
Fluorescent Antibody Technique
1
2004
390
0.050
Why?
beta Catenin
1
2025
253
0.050
Why?
Macromolecular Substances
2
2003
229
0.050
Why?
Promoter Regions, Genetic
3
2005
1251
0.050
Why?
src-Family Kinases
1
2003
92
0.050
Why?
Sequence Analysis, RNA
1
2025
452
0.050
Why?
Animals
9
2012
36951
0.050
Why?
Tissue Donors
1
2005
425
0.050
Why?
Mice
6
2012
17794
0.050
Why?
Mice, Knockout
2
2012
3018
0.050
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2005
289
0.050
Why?
Recurrence
3
2013
1061
0.050
Why?
Cell Differentiation
2
2000
1991
0.050
Why?
Academic Medical Centers
1
2025
512
0.050
Why?
Survivors
2
2016
494
0.050
Why?
Central Nervous System
1
2024
258
0.050
Why?
Databases, Factual
2
2018
1357
0.050
Why?
Enzyme-Linked Immunosorbent Assay
1
2004
853
0.050
Why?
Cells, Cultured
3
2005
4193
0.050
Why?
Survivorship
1
2022
52
0.040
Why?
Protein-Tyrosine Kinases
2
2008
434
0.040
Why?
Proto-Oncogene Protein c-fli-1
1
2021
25
0.040
Why?
RNA-Binding Protein EWS
1
2021
26
0.040
Why?
Hypertension, Pulmonary
1
2012
1910
0.040
Why?
Kidney Diseases, Cystic
1
2021
24
0.040
Why?
Receptor Aggregation
1
2000
11
0.040
Why?
Transcription, Genetic
2
2005
1457
0.040
Why?
Tumor Microenvironment
1
2025
676
0.040
Why?
Pneumothorax
1
2021
38
0.040
Why?
Curriculum
1
2007
996
0.040
Why?
Translocation, Genetic
1
2021
105
0.040
Why?
Reoviridae
1
2000
37
0.040
Why?
Chemokine CXCL9
1
2020
27
0.040
Why?
Syndrome
1
2021
358
0.040
Why?
Germ-Line Mutation
1
2021
172
0.040
Why?
Mutagenesis, Site-Directed
1
2000
375
0.040
Why?
Surveys and Questionnaires
2
2022
5793
0.040
Why?
p38 Mitogen-Activated Protein Kinases
1
2000
283
0.040
Why?
Mating Factor
1
1999
3
0.040
Why?
Cell Compartmentation
1
1999
52
0.040
Why?
Receptors, Growth Factor
1
1999
55
0.040
Why?
Follow-Up Studies
2
2020
5136
0.040
Why?
Oncogene Proteins, Fusion
1
2021
215
0.040
Why?
Gene Expression Regulation, Neoplastic
1
2025
1396
0.040
Why?
Growth Substances
1
1999
147
0.040
Why?
Insect Proteins
1
1999
39
0.040
Why?
Proto-Oncogene Proteins
1
2002
648
0.040
Why?
TRPP Cation Channels
1
2019
85
0.040
Why?
Fungal Proteins
1
1999
123
0.040
Why?
Transcriptional Activation
1
2000
378
0.040
Why?
Age of Onset
1
2020
520
0.040
Why?
Education, Medical, Graduate
1
2022
486
0.040
Why?
MAP Kinase Kinase 5
3
2003
4
0.040
Why?
Gene Expression Profiling
1
2025
1775
0.040
Why?
Cytoskeleton
1
1999
191
0.040
Why?
Chronic Disease
2
2015
1794
0.030
Why?
Dexamethasone
1
2020
370
0.030
Why?
Kaplan-Meier Estimate
1
2020
889
0.030
Why?
Membrane Glycoproteins
1
2000
500
0.030
Why?
DNA-Binding Proteins
1
2005
1502
0.030
Why?
Combined Modality Therapy
1
2020
1236
0.030
Why?
Mammals
1
1999
283
0.030
Why?
Drug Therapy, Combination
1
2020
1067
0.030
Why?
Receptors, Cell Surface
1
2019
385
0.030
Why?
United States
3
2022
14870
0.030
Why?
Drosophila melanogaster
1
1999
233
0.030
Why?
Hepatoblastoma
1
2017
46
0.030
Why?
Intraoperative Period
1
2017
59
0.030
Why?
Incidence
1
2024
2804
0.030
Why?
Microtubules
1
1999
279
0.030
Why?
Anti-Inflammatory Agents
1
2020
496
0.030
Why?
Epidemiological Monitoring
1
2016
63
0.030
Why?
Stress, Physiological
1
1999
443
0.030
Why?
Caenorhabditis elegans
1
1999
306
0.030
Why?
Time Factors
2
2018
6834
0.030
Why?
Neurilemmoma
1
2014
24
0.030
Why?
Organizational Innovation
1
2015
140
0.030
Why?
Saccharomyces cerevisiae
1
1999
557
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2020
622
0.030
Why?
Interdisciplinary Communication
1
2015
191
0.030
Why?
Parents
1
2022
1350
0.030
Why?
Peptides
1
1999
985
0.030
Why?
Reproducibility of Results
1
2021
3290
0.030
Why?
Lymphoma
1
2014
212
0.020
Why?
Neoplasm Staging
1
2017
1389
0.020
Why?
MAP Kinase Kinase 7
2
2003
8
0.020
Why?
Logistic Models
1
2018
2075
0.020
Why?
RNA, Messenger
1
2000
2834
0.020
Why?
Analysis of Variance
1
2015
1316
0.020
Why?
Two-Hybrid System Techniques
2
2003
59
0.020
Why?
T-Lymphocytes
1
2000
1998
0.020
Why?
Colorado
2
2015
4576
0.020
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
2
2002
30
0.020
Why?
fas Receptor
2
2002
95
0.020
Why?
Program Evaluation
1
2015
901
0.020
Why?
Caspases
2
2002
247
0.020
Why?
Treatment Outcome
2
2020
10837
0.020
Why?
Aged
2
2022
24001
0.020
Why?
Inflammation Mediators
1
2012
513
0.020
Why?
Transfection
2
2003
945
0.020
Why?
Receptor, IGF Type 1
1
2008
65
0.020
Why?
Ultrasonography
1
2012
763
0.020
Why?
Chemistry, Pharmaceutical
1
2008
105
0.020
Why?
Practice Patterns, Physicians'
1
2017
1313
0.020
Why?
Drug Design
1
2008
167
0.020
Why?
Bone Marrow Transplantation
1
2008
286
0.020
Why?
Schools, Medical
1
2007
147
0.020
Why?
Pancreatic Neoplasms
1
2014
938
0.020
Why?
Clinical Clerkship
1
2007
101
0.020
Why?
Medical Oncology
1
2008
293
0.020
Why?
Vascular Endothelial Growth Factor A
1
2008
545
0.020
Why?
Histocompatibility Testing
1
2005
126
0.020
Why?
Protein Binding
2
2003
2224
0.010
Why?
Fos-Related Antigen-2
1
2005
1
0.010
Why?
Oligonucleotide Probes
1
2005
51
0.010
Why?
Prospective Studies
1
2017
7623
0.010
Why?
Urokinase-Type Plasminogen Activator
1
2005
29
0.010
Why?
Tetradecanoylphorbol Acetate
1
2005
150
0.010
Why?
Middle Aged
2
2017
33554
0.010
Why?
Dimerization
1
2005
199
0.010
Why?
Transplantation, Homologous
1
2005
416
0.010
Why?
Faculty, Medical
1
2007
283
0.010
Why?
Aged, 80 and over
1
2016
7637
0.010
Why?
Flow Cytometry
1
2008
1178
0.010
Why?
MEF2 Transcription Factors
1
2003
61
0.010
Why?
Clinical Trials as Topic
1
2008
1052
0.010
Why?
Graft vs Host Disease
1
2005
252
0.010
Why?
Mink
1
2003
12
0.010
Why?
Osmolar Concentration
1
2003
171
0.010
Why?
Amino Acid Motifs
1
2003
225
0.010
Why?
Disease Models, Animal
1
2012
4295
0.010
Why?
Multivariate Analysis
1
2005
1509
0.010
Why?
Caspase 3
1
2002
246
0.010
Why?
Cell Nucleus
1
2005
620
0.010
Why?
Models, Biological
1
2008
1783
0.010
Why?
Base Sequence
1
2005
2181
0.010
Why?
MAP Kinase Kinase Kinase 3
1
2000
4
0.010
Why?
Fas-Associated Death Domain Protein
1
2000
9
0.010
Why?
Caspase 8
1
2000
48
0.010
Why?
Caspase 9
1
2000
57
0.010
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2000
52
0.010
Why?
COS Cells
1
2000
188
0.010
Why?
Phosphatidylinositol 3-Kinases
1
2002
366
0.010
Why?
Antigen-Presenting Cells
1
2000
156
0.010
Why?
Caspase Inhibitors
1
2000
81
0.010
Why?
Oxidants
1
2000
111
0.010
Why?
Molecular Sequence Data
1
2005
2900
0.010
Why?
Proto-Oncogene Proteins c-akt
1
2002
437
0.010
Why?
Apoptosis Regulatory Proteins
1
2000
188
0.010
Why?
Hydrogen Peroxide
1
2000
328
0.010
Why?
Mitosis
1
1999
192
0.010
Why?
Epithelial Cells
1
2003
1096
0.010
Why?
Lymphocyte Activation
1
2000
1142
0.010
Why?
Oxidative Stress
1
2003
1317
0.010
Why?
Kidney
1
2003
1475
0.010
Why?
Garrington's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)